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Abstract
Dietary calcium lowers the risk of nephrolithiasis due to a decreased
absorption of dietary oxalate that is bound by intestinal calcium. The
aim of the present study was to evaluate oxaluria in normocalciuric
and hypercalciuric lithiasic patients under different calcium intake.
Fifty patients (26 females and 24 males, 41 ± 10 years old), whose 4-
day dietary records revealed a regular low calcium intake (≤500 mg/
day), received an oral calcium load (1 g/day) for 7 days. A 24-h urine
was obtained before and after load and according to the calciuria under
both diets, patients were considered as normocalciuric (NC, N = 15),
diet-dependent hypercalciuric (DDHC, N = 9) or diet-independent
hypercalciuric (DIHC, N = 26). On  regular diet, mean oxaluria was 30
± 14 mg/24 h for all patients. The 7-day calcium load induced a
significant decrease in mean oxaluria compared to the regular diet in
NC and DIHC (20 ± 12 vs 26 ± 7 and 27 ± 18 vs 32 ± 15 mg/24 h,
respectively, P<0.05) but not in DDHC patients (22 ± 10 vs 23 ± 5 mg/
24 h). The lack of an oxalate decrease among DDHC patients after the
calcium load might have been due to higher calcium absorption under
higher calcium supply, with a consequent lower amount of calcium
left in the intestine to bind with oxalate. These data suggest that a long-
lasting regular calcium consumption <500 mg was not associated with
high oxaluria and that a subpopulation of hypercalciuric patients who
presented a higher intestinal calcium absorption (DDHC) tended to
hyperabsorb oxalate as well, so that oxaluria did not change under
different calcium intake.
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Introduction
The prevalence of nephrolithiasis may be
affected by genetic, environmental and nu-
tritional factors (1). In the past, calcium re-
striction became a very popular recommen-
dation based on the high prevalence (about
50%) of idiopathic hypercalciuria in calcium
stone-forming patients (2), its impact on cal-
cium oxalate and phosphate saturation (3),
and also because of the contribution of cal-
cium intake to hypercalciuria. Indeed, idio-
pathic hypercalciuria may be ascribed to an
increased intestinal calcium absorption, in-
creased bone resorption and decreased renal
tubular calcium reabsorption (4). However,
there is no evidence that a reduction in di-
etary calcium intake prevents stone recur-
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rence. A large prospective dietary survey of
healthy men showed an increase rather than
a decrease in stone disease incidence when
dietary calcium intake was below 516 mg/
day (5), probably due to an increased free
oxalate concentration in the intestinal lumen
owing to less calcium to bind with. As urine
normally contains much less oxalate than
calcium, small increases in urinary oxalate
concentration will have a relatively greater
effect on calcium oxalate supersaturation
than great changes in calcium concentration.
In a previous study (6), we observed that
Brazilian calcium stone-forming and healthy
subjects have a low calcium intake, not higher
than 500 mg/day, reaching only 30 to 50% of
the recommended dietary allowances, as part
of their dietary habit. The aim of the present
study was to evaluate the urinary excretion
of oxalate in calcium stone-forming patients
who chronically consumed a low calcium
diet, and to examine the effects of an in-
crease in calcium intake on urinary oxalate
excretion in normocalciuric and hypercal-
ciuric calcium stone-forming patients.
Subjects and Methods
Subjects
Sixty-five calcium stone-forming patients
with normal renal function were referred to
the Renal Lithiasis Unit of the Nephrology
Division, Universidade Federal de São Paulo,
São Paulo, SP, Brazil, because of stone for-
mation. The diagnosis of stone formation
was based on a history of colic episodes with
expulsion of stones (spontaneous or after
shock wave lithotripsy) and previous or pres-
ent radiographic evidence of radiopaque
stones. Patients with diseases affecting cal-
cium metabolism (primary hyperparathyroid-
ism, hyperthyroidism, acromegaly, sarcoi-
dosis, diabetes, neoplasias, etc.) or taking
drugs which could not be withdrawn during
the protocol (corticosteroids, inhibitors of
prostaglandin synthesis, diuretics, oral con-
traceptives, anticonvulsants, etc.) were not
included in the study. After an initial clinical
evaluation, all of them were submitted to a 4-
day dietary record. Fifty of the 65 calcium
stone-forming patients whose dietary records
disclosed a regular calcium intake below
500 mg/day were included in the study. Writ-
ten informed consent was obtained from all
patients and the study was approved by the
Ethics Committee of the Universidade
Federal de São Paulo.
Twenty-two healthy volunteers (9 males
and 13 females) who had never formed a
kidney stone underwent a 24-h urinary ox-
alate excretion determination as controls. A
4-day dietary assessment could not be ob-
tained for these controls.
Methods
Baseline dietary record. During the base-
line period, dietary habit was assessed
through a 4-day dietary record. Subjects were
instructed to keep a daily record describing
the amount of each food consumed and not
modifying their habitual diet. After the
records were received, the same nutritionist
evaluated the daily food record during an
interview. Calcium, oxalate and other nutri-
ent intakes were calculated using a computer
program (6). For better accuracy, NaCl in-
take was calculated based on the levels of
urinary sodium rather than on the dietary
record.
Baseline urinary parameters. A 24-h
urine sample was collected on the 4th day of
the dietary record to determine calcium, so-
dium, potassium, creatinine and oxalate. On
a different occasion, a 12-h fasting urine
sample was obtained from 18 of the 35 hy-
percalciuric patients for determination of
urinary fasting Ca/Cr ratio.
Chronic oral calcium load. The chronic
oral calcium load consisted of 1 g of calcium
(500 mg bid) administered orally at meal-
time for 7 days, in addition to their regular
diet with the timing of calcium load identical
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for all groups. During this period, patients
were instructed by the nutritionist to main-
tain their regular intake of calcium and ox-
alate to match the intake reported in the first
dietary record.
Post-load dietary record. A second 4-
day dietary record was then obtained from
every patient to ensure that the calcium and
oxalate intakes of both records were similar,
with the calcium supplements being the single
difference between the two periods. Sub-
jects who had modified their diet were not
included in the study.
Post-load urinary parameters. A 24-h
urine sample was collected on the 4th day to
determine calcium and oxalate.
Laboratory analysis
Urinary oxalate was measured by an en-
zymatic method (7) based on the oxidation
of oxalate by oxalate oxidase followed by
measurement of hydrogen peroxide produced
during the reaction by a peroxidase-cata-
lyzed reaction using the Sigma Oxalate Di-
agnostic kit (Sigma, St. Louis, MO, USA).
The urine samples were acidified below pH
2.0. The normal limit of oxalate was consid-
ered to be <44 mg/24 h. Calcium was deter-
mined by atomic absorption spectrophotom-
etry (Perkin-Elmer Atomic Spectrophotom-
eter 290B, Norwalk, CT, USA). Creatinine
was measured by the alkaline picrate Jaffe
reaction (8) and uric acid by the uricase
method (9). Urinary citrate was determined
by the citrate-lyase enzymatic reaction (10).
Sodium and potassium were measured by
flame emission spectrophotometry.
Statistical analysis
Nonparametric tests were used (Kruskal-
Wallis complemented by the Dunn test) to
compare the results of all groups. The Wil-
coxon test was used to compare results ob-
tained after calcium load versus regular diet
in the same group. Statistical significance
was defined as P<0.05.
Results
Fifty calcium stone-forming patients, 26
females and 24 males, 41 ± 10 years old,
were evaluated. They presented significant-
ly higher urinary calcium and oxalate levels
when compared to 22 healthy subjects (236
± 103 vs 181 ± 58 and 30 ± 14 vs 22 ± 11 mg/
24 h, P<0.05, respectively). Mean urinary
parameters obtained under the regular diet
and after the calcium load are shown in
Table 1. Urinary calcium, sodium, potas-
sium and creatinine levels after calcium load
did not differ from those obtained during the
regular diet. Conversely, urinary oxalate was
significantly decreased after the calcium load
(25 ± 15 vs 30 ± 14 mg/24 h, P<0.05).
The 50 calcium stone-forming subjects
were classified according to the levels of
24-h urinary calcium on their regular diet
and after the calcium load. Patients who
presented urinary calcium excretion ≤4 mg
kg-1 24 h-1 on their regular diet and after a
calcium load were classified as normocal-
ciuric (NC, N = 15). Patients with urinary
calcium excretion ≤4 mg kg-1 24 h-1 on their
usual diet and >4 mg kg-1 24 h-1 following the
calcium load were classified as diet-depend-
ent hypercalciuric (DDHC, N = 9) and those
presenting urinary calcium excretion ≥4 mg
kg-1 24 h-1 on their low-calcium regular diet
(calcium intake ≤500 mg/day) were classi-
fied as diet-independent hypercalciuric
(DIHC, N = 26).
Table 1. Twenty-four-hour urinary parameters under regular diet conditions and after
calcium load in 50 calcium stone-forming patients.
Calcium Oxalate Sodium Potassium Creatinine
(mg/24 h) (mg/24 h) (mEq/24 h) (mEq/24 h) (mg/24 h)
Regular diet 236 ± 103 30 ± 14 238 ± 103 50 ± 20 1322 ± 351
After calcium load 280 ± 118* 25 ± 15* 251 ± 87 53 ± 20 1327 ± 363
Data are reported as means ± SD.
*P<0.05 vs regular diet (Wilcoxon’s test).
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Isolated hypocitraturia was detected in
18 (36%) patients, hypocitraturia associated
with hyperuricosuria was found in 3 (6%),
and hyperuricosuria in 4 patients (8%).
Table 2 shows the mean values of cal-
cium, oxalate and sodium chloride intakes
obtained from dietary records on the regular
diet and after a calcium load. The sodium
chloride intake was calculated from 24-h
urinary sodium excretion. As a consequence
of the supplement given for 7 days, calcium
intake was significantly higher compared to
the period of regular diet. Oxalate and so-
dium intake did not change.
Table 3 shows mean urinary calcium and
oxalate levels on the regular diet and after
the calcium load. On the regular diet, the
DIHC group presented a significantly higher
urinary calcium excretion than NC and
DDHC (322 ± 62 vs 124 ± 30 and 189 ± 30
mg/24 h, respectively). When corrected for
body weight, urinary calcium continued to
be significantly higher in the DIHC group
than in the NC and DDHC groups (4.8 ± 0.7
vs 1.8 ± 0.5 and 2.9 ± 0.8 mg kg-1 24 h-1) but
the mean weight was similar for the NC,
DDHC and DIHC groups (67 ± 10, 68 ± 18
and 67 ± 13 kg, respectively) (data not
shown). On a regular diet, the urinary ox-
alate excretion was significantly higher in
DIHC than DDHC (32 ± 15 vs 23 ± 5 mg/24
h). In the post-load period, urinary calcium
was significantly higher in both hypercalciu-
ric groups (DDHC and DIHC) when com-
pared to the NC group, who remained nor-
mocalciuric (386 ± 90 and 314 ± 10 vs 164 ±
44 mg/24 h, respectively). Urinary oxalate
did not differ between groups.
When compared to the period of regular
diet, calcium load induced a significant in-
crease in calciuria in NC (124 ± 30 vs 164 ±
44 mg/24 h) and in DDHC (189 ± 30 vs 386
± 90 mg/24 h) but not in DIHC (322 ± 62 vs
314 ± 10 mg/24 h).
In 18 patients of the DIHC group submit-
ted to the determination of urinary fasting
Ca/Cr ratio, 11 patients (61%) presented a
fasting Ca/Cr ratio ≥0.11 and 7 (39%) <0.11
(data not shown).
Chronic calcium load induced a signifi-
cant decrease in mean oxalate excretion in
the NC and DIHC groups (20 ± 7 vs 26 ± 12
and 27 ± 18 vs 32 ± 15 mg/24 h, P<0.05,
respectively) but not in DDHC (22 ± 10 vs 23
± 5 mg/24 h).
Individual values of urinary oxalate within
each group are illustrated in Figure 1.
Hyperoxaluria (urinary oxalate >44 mg/24
h) was observed in 2 patients (13%) of the
NC group, as shown in Figure 1A, and in 3
patients (11%) of the DIHC group (Figure
1C). Hyperoxaluria was not observed in the
DDHC group. As depicted in Figure 1A,
Table 3. Urinary calcium and oxalate excretion (mg/24 h) in normocalciuric (NC), diet-
dependent (DDHC) and diet-independent (DIHC) hypercalciuric patients.
NC (N = 15) DDHC (N = 9) DIHC (N = 26)
Urinary calcium
Regular diet 124 ± 30 189 ± 30 322 ± 62#+
After calcium load 164 ± 44*  386 ± 90*# 314 ± 10#
Urinary oxalate
Regular diet 26 ± 12 23 ± 5 32 ± 15+
After calcium load 20 ± 7* 22 ± 10 27 ± 18*
Data are reported as means ± SD.
*P<0.05 vs regular diet (Wilcoxon’ test). #P<0.05 vs NC; +P<0.05 vs DDHC (Kruskal-
Wallis complemented by Dunn test).
Table 2. Dietary intake of calcium, oxalate and sodium by patients on a regular diet and
after calcium load.
NC (N = 15) DDHC (N = 9) DIHC (N = 26)
Regular diet
Calcium (mg/day) 458 ± 172 460 ± 223 440 ± 153
Oxalate (mg/day) 54 ± 30 38 ± 23 61 ± 50
NaCl (g/day) 13 ± 5 12 ± 5 15 ± 7
After calcium load
Calcium (mg/day) 1464 ± 191* 1454 ± 262* 1536 ± 209*
Oxalate (mg/day) 49 ± 32 44 ± 23 62 ± 58
NaCl (g/day) 14 ± 5 14 ± 5 15 ± 5
Data are reported as means ± SD. NC = normocalciuric group; DDHC = diet-dependent
hypercalciuric group; DIHC = diet-independent hypercalciuric group.
*P<0.05 vs regular diet (Wilcoxon’s test).
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8 NC (53%) patients decreased their urinary
oxalate after the calcium load. As shown in
Figure 1B, 4 DDHC (44%) patients decreased
urinary oxalate after the calcium load, while
18 DIHC (69%) patients did so (Figure 1C).
The percentages of patients who presented
such a decrease in the NC and DIHC groups
were higher (53 and 69%), albeit not signifi-
cantly so, when compared to DDHC patients
(44%).
Discussion
In the past, since increased calcium in-
take was considered to be an important risk
factor for stone formation, calcium restric-
tion was recommended as an obvious inter-
vention to prevent kidney stones in calcium
stone-forming patients suffering from hy-
percalciuria (11). However, this practice has
been questioned due to a large epidemio-
logic study which reported an increased risk
for stone formation in subjects consuming a
low calcium diet due to secondary
hyperoxaluria (5), although these data had
been largely indirect. Furthermore, several
investigators have observed that calcium re-
striction has a deleterious effect on bone in
hypercalciuric patients (12,13).
In healthy subjects, Hess et al. (14) ob-
served that an increased calcium intake can
totally abolish the hyperoxaluria induced by
an oxalate load. However, Bushinsky et al.
(15), in an experimental model of genetic
hypercalciuric rats, observed that, although
urinary calcium proportionally increased with
increasing dietary calcium content, a paral-
lel decrease in urinary oxalate did not occur.
The present study was undertaken on the
basis of these observations in order to evalu-
ate two important aspects regarding oxaluria
in calcium stone-forming patients. First, to
determine urinary oxalate levels in patients
with habitual low calcium intake, as it is the
case in our population (6), and second, to
determine whether the postulated inverse
relationship between colonic oxalate absorp-
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tion and colonic calcium load is modified
when hypercalciuria is present.
In the present series, the entire group of
calcium stone-forming patients presented a
significantly higher mean oxalate urinary
excretion than healthy subjects (30 vs 22 mg/
24 h) while consuming a diet containing no
more than 500 mg/day of calcium. However,
this mean oxalate excretion did not differ
from the values reported for calcium stone-
forming patients with a calcium intake of
about 1000 mg/day by our service and others
(16,17).
Mild hyperoxaluria is defined by urinary
oxalate excretion higher than 40 or 45 mg/
day according to some investigators (18,19),
or even higher than 33 mg/day according to
others (20,21). However, the question of the
optimal method for measurement of urinary
oxalate is still debated. The large number of
analytical procedures used, such as precipi-
tation (22), colorimetric procedures (23),
chromatography and enzymatic methods (7)
limits comparison of the results of different
groups. In the present study, the enzymatic
method was chosen because it is simple,
inexpensive and in many ways equivalent to
other methods.
Of 50 calcium stone-forming patients, 5
(10%) presented hyperoxaluria (2 patients
belonged to the normocalciuric group and
the other 3 to the hypercalciuric group). This
incidence of hyperoxaluria is similar to pre-
vious reports of 12 to 17% by others (19,24).
The second purpose of this study was to
evaluate oxalate excretion under a higher
calcium intake in normocalciuric and hyper-
calciuric patients, with the latter being clas-
sified according to their response to the cal-
cium load as diet-dependent or -independent
patients. The increase in urinary calcium
after the calcium load, not biased by a higher
salt intake (NaCl intake was similar in both
dietary conditions), suggested that 9 hyper-
calciuric patients were dietary calcium-
dependent.
The increased urinary calcium under con-
ditions of regular low calcium intake and the
lack of increase in urinary calcium following
the calcium load suggested that a decreased
renal tubular reabsorption and/or increased
bone resorption might have accounted for
the hypercalciuria in the 26 DIHC patients.
In 11/18 (61%) of these patients a high fast-
ing Ca/Cr ratio was detected, indicating a
renal leak and/or an increased bone resorp-
tion. In the remaining 7 (39%), a type I
absorptive hypercalciuria might have been
present.
However, the evaluation of oxalate ex-
cretion during the use of both calcium diets
revealed different changes according to the
influence of calcium intake on calcium ex-
cretion.
After increasing calcium intake from 500
to 1500 mg/day through calcium supple-
ments, NC and DIHC patients presented sig-
nificantly reduced mean urinary oxalate lev-
els compared to baseline (20 ± 7 vs 26 ± 12
and 27 ± 18 vs 32 ± 15 mg/24 h, respec-
tively). The dietary calcium-induced varia-
tion of about 20% in mean oxaluria, ob-
served in NC and DIHC patients, agrees well
with that reported by other investigators
(11,17).
The lack of oxalate decrease in DDHC
patients might have been due to a higher
calcium absorption under conditions of a
higher calcium supply, with a consequent
lower amount of calcium in the intestinal
lumen to bind oxalate with.
A reduction in calcium intake is deleteri-
ous for calcium stone-forming patients what-
ever their calciuria classification. In DIHC
patients, a reduction in calcium intake is
undesirable because in addition to not pro-
moting a change in urinary calcium and be-
ing deleterious to bone, it induces secondary
hyperoxaluria. DDHC patients are not prone
to variations in oxaluria but a low calcium
diet would probably worsen their bone con-
dition, as previously reported (25-27).
The data indicate that in the present se-
ries a long-lasting usual daily calcium con-
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sumption <500 mg was not associated with
high levels of urinary oxalate and that a
subpopulation of hypercalciuric patients, i.e.,
the diet-dependent patients, who present a
higher intestinal calcium absorption, tended
to hyperabsorb oxalate as well, so that uri-
nary oxalate did not change under different
calcium intake conditions.
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